Workflow
PROCEPT BioRobotics (PRCT)
icon
Search documents
PROCEPT BioRobotics (PRCT) - 2021 Q4 - Annual Report
2022-03-22 20:03
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 10-K ___________________________________ (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-04321 ___________________ ...
PROCEPT BioRobotics (PRCT) - 2021 Q4 - Earnings Call Transcript
2022-03-08 16:37
PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2021 Earnings Conference Call March 8, 2022 8:00 AM ET Company Participants Reza Zadno – Chief Executive Officer Matt Bacso – Gilmartin Group Kevin Waters – Chief Financial Officer Conference Call Participants Craig Bijou – Bank of America Phil Ames – Goldman Sachs Chris Pasquale – Guggenheim Anne Hite – SVB Leerink Operator Good morning, ladies and gentlemen. And welcome to PROCEPT BioRobotics Fourth-quarter earnings conference call. At this time, all participants are i ...
PROCEPT BioRobotics (PRCT) - 2021 Q3 - Earnings Call Transcript
2021-11-07 13:05
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Matt Bacso – Investor Relations Reza Zadno – Chief Executive Officer Kevin Waters – Chief Financial Officer Conference Call Participants Josh Jennings – Cowen Amit Hazan – Goldman Sachs Chris Pasquale – Guggenheim Danielle Antalffy – SVB Leerink Operator Good afternoon, and welcome to PROCEPT BioRobotics Third Quarter Earnings Conference Call. [Operator instructions] We will be fac ...
PROCEPT BioRobotics (PRCT) - 2021 Q3 - Quarterly Report
2021-11-05 20:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40797 PROCEPT BioRobotics Corporation (Exact name of registrant as specified in its charter) | Delaware | | | 26-0199180 | | ...